Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer episode artwork

EPISODE · Aug 5, 2024 · 1H

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

from Lung Cancer Update

Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 datasets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations.

Episode metadata supplied by the publisher feed · Published Aug 5, 2024

Embed this episode

Ready to play

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

0:00 1:00:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Lung Cancer Update?

This episode is 1 hour and 0 minutes long.

When was this Lung Cancer Update episode published?

This episode was published on August 5, 2024.

Can I download this Lung Cancer Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!